Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study

Table 3 Neurotoxicity based on previous patients’ neuropathy

Previous neurotoxicity	Neurotoxicity during eribulin treatment
	G0	G1	G2	G3	Total
	n (%)	n (%)	n (%)	n (%)	Total
No	105 (73.4)	19 (13.3)	18 (12.6)	1 (0.7)	143
Yes	9 (33.3)	12 (44.4)	2 (7.4)	4 (14.8)	27
Total	114	31	20	5	170

ISSN: 1465-542X